SGSH gene

Known as: N-sulfoglucosamine sulfohydrolase, HEPARAN SULFATE SULFATASE, SGSH 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1974-2017
024619742017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
There is no treatment for the progressive neurodegenerative lysosomal storage disorder mucopolysaccharidosis type IIIA (MPS IIIA… (More)
Is this relevant?
2010
2010
Many viral backbones have been used as gene transfer vectors. However, the efficacy of therapy based on human-derived vectors may… (More)
Is this relevant?
2009
2009
Mucopolysaccharidosis type IIIA (MPS IIIA) results from lack of functional sulfamidase (SGSH), a lysosomal enzyme. Its substrate… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2007
2007
OBJECTIVE Mucopolysaccharidosis types IIIA through IIID (Sanfilippo syndrome) are caused by deficiencies of enzymes involved in… (More)
  • table 1
  • table 2
  • table 4
  • table 3
  • figure 1
Is this relevant?
2007
2007
Mucopolysaccharidosis type IIIA (MPS-IIIA or Sanfilippo syndrome) is a lysosomal storage disorder caused by the congenital… (More)
Is this relevant?
2006
2006
The original mucopolysaccharidosis type IIIA (MPS IIIA) mice were identified in a mixed background with contributions from four… (More)
Is this relevant?
2006
2006
Heparan sulfate is a linear glycosaminoglycan with considerable structural diversity that binds a myriad of growth factors and… (More)
Is this relevant?
2005
2005
Mucopolysaccharidosis (MPS) type IIIA or Sanfilippo syndrome is a lysosomal storage disorder characterised by progressive… (More)
Is this relevant?
2002
2002
Mucopolysaccharidosis type IIIA (MPS IIIA) is an autosomal recessive disease that occurs due to a deficiency of heparan sulfate… (More)
Is this relevant?
1999
1999
Mucopolysaccharidosis type IIIA (SanÐlippo A; McKusick 25290) is caused by a deÐciency of lysosomal sulphamidase activity (EC 3… (More)
  • table 1
Is this relevant?